(Q34233263)

31 July 2017

1 reference

title

Review of macrolides and ketolides: focus on respiratory tract infections (English)

1 reference

31 July 2017

Zhanel GG

1

1 reference

31 July 2017

Dueck M

2

1 reference

31 July 2017

Hoban DJ

3

1 reference

31 July 2017

Vercaigne LM

4

1 reference

31 July 2017

Embil JM

5

1 reference

31 July 2017

Gin AS

6

1 reference

31 July 2017

Karlowsky JA

7

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

61

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

443-498

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200161040-00003

31 July 2017

exact match

0 references

cites work

Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media

1 reference

12 December 2020

A practical guide for the diagnosis and treatment of acute sinusitis.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions

1 reference

12 December 2020

Comparative efficacy of erythromycin-sulfisoxazole, cefaclor, amoxicillin or placebo for otitis media with effusion in children

1 reference

12 December 2020

Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)

1 reference

12 December 2020

Spiramycin renaissance

1 reference

12 December 2020

In-vitro activity of ketolides against mycoplasmas

1 reference

12 December 2020

In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

1 reference

12 December 2020

Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin

1 reference

12 December 2020

Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia

1 reference

12 December 2020

Ketolides lack inducibility properties of MLS(B) resistance phenotype

1 reference

12 December 2020

Penetration of azithromycin into middle ear effusions in acute and secretory otitis media in children.

1 reference

12 December 2020

In vitro activity of the new ketolide HMR3647 in comparison with those of macrolides and pristinamycins against Enterococcus spp.

1 reference

12 December 2020

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

1 reference

12 December 2020

Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group

1 reference

12 December 2020

Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status

1 reference

12 December 2020

Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system

1 reference

12 December 2020

Inhibitory effect of ofloxacin on acute exacerbations of chronic respiratory tract infections in comparison with erythromycin

1 reference

12 December 2020

Comparative trial of 3 days of azithromycin versus 10 days of clarithromycin in the treatment of children with acute otitis media with effusion

1 reference

12 December 2020

Pharmacokinetic drug interactions of macrolides

1 reference

12 December 2020

A comparison of the efficacy, tolerability and safety of azithromycin and co-amoxiclav in the treatment of sinusitis in adults

1 reference

12 December 2020

The importance of penetration of antimicrobial agents into cells.

1 reference

12 December 2020

The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration

1 reference

12 December 2020

Optimum treatment of streptococcal pharyngitis

1 reference

12 December 2020

Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis

1 reference

12 December 2020

Roxithromycin: review of its antimicrobial activity

1 reference

12 December 2020

Azithromycin. A review of its use in paediatric infectious diseases

1 reference

12 December 2020

Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group

1 reference

12 December 2020

Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin

1 reference

12 December 2020

New directions for macrolide antibiotics: structural modifications and in vitro activity

1 reference

12 December 2020

A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre

1 reference

12 December 2020

Economic analysis of treatment with roxithromycin in comparison with erythromycin in patients with lower respiratory tract infections

1 reference

12 December 2020

Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva

1 reference

12 December 2020

Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses

1 reference

12 December 2020

[Azithromycin: tissue pharmacology]

1 reference

12 December 2020

Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus

1 reference

12 December 2020

Clarithromycin and azithromycin: new macrolide antibiotics

1 reference

12 December 2020

In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae

1 reference

12 December 2020

Macrolide antibacterials. Drug interactions of clinical significance

1 reference

12 December 2020

Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens

1 reference

12 December 2020

The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans

1 reference

12 December 2020

Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.

1 reference

12 December 2020

Macrolides and host defences to respiratory tract pathogens

1 reference

12 December 2020

Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004)

1 reference

12 December 2020

Azithromycin drug interactions

1 reference

12 December 2020

Comparison of macrolide antibiotics

1 reference

12 December 2020

Clinical and financial impact of intravenous erythromycin therapy in hospitalized patients

1 reference

12 December 2020

In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.

1 reference

12 December 2020

A multicenter, double blind comparison of azithromycin and amoxicillin/ clavulanate for the treatment of acute otitis media in children

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils.

1 reference

12 December 2020

A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease

1 reference

12 December 2020

Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.

1 reference

12 December 2020

Mechanism of action of spiramycin and other macrolides

1 reference

12 December 2020

Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course

1 reference

12 December 2020

Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of antibiotics in otitis media

1 reference

12 December 2020

Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect

1 reference

12 December 2020

Oral therapy with flurithromycin in ear, nose and throat infections

1 reference

12 December 2020

Comparative pharmacology of josamycin and erythromycin stearate

1 reference

12 December 2020

Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria

1 reference

12 December 2020

Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society

1 reference

12 December 2020

Investigation of dirithromycin and erythromycylamine uptake by human neutrophils in vitro

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

The penetration of macrolides into bronchial secretions.

1 reference

12 December 2020

Phagocyte uptake and transport of azithromycin

1 reference

12 December 2020

Inhibition of protein synthesis by streptogramins and related antibiotics

1 reference

12 December 2020

Choosing the right macrolide antibiotic. A guide to selection

1 reference

12 December 2020

1 reference

12 December 2020

Azithromycin compared with clarithromycin for the treatment of streptococcal pharyngitis in children

1 reference

12 December 2020

Penetration of erythromycin into tonsillar tissue

1 reference

12 December 2020

Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group

1 reference

12 December 2020

Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media

1 reference

12 December 2020

An evaluation of tolerance of roxithromycin in adults

1 reference

12 December 2020

Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin

1 reference

12 December 2020

Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA

1 reference

12 December 2020

The effect of erythromycin on resolution of symptoms among adults with pharyngitis not caused by group A streptococcus

1 reference

12 December 2020

Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole

1 reference

12 December 2020

A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis

1 reference

12 December 2020

Clinical efficacy of dirithromycin in patients with bacteremic pneumonia.

1 reference

12 December 2020

Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae

1 reference

12 December 2020

Tissue distribution of roxithromycin

1 reference

12 December 2020

Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children.

1 reference

12 December 2020

A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections

1 reference

12 December 2020

Ribosome-catalysed peptidyl transfer: effects of some inhibitors of protein synthesis

1 reference

12 December 2020

Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy

1 reference

12 December 2020

Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997-1998

1 reference

12 December 2020

Clinical toleration and safety of azithromycin

1 reference

12 December 2020

The new fluoroquinolones: A critical review

1 reference

12 December 2020

Etiology and treatment of community-acquired pneumonia in ambulatory children

1 reference

12 December 2020

An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.

1 reference

12 December 2020

Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children

1 reference

12 December 2020

Azithromycin: the first azalide antibiotic

1 reference

12 December 2020

In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004

1 reference

12 December 2020

Erythromycin resistance by ribosome modification

1 reference

12 December 2020

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

12 December 2020

Clinical effect of low-dose, long-term roxithromycin chemotherapy in patients with chronic sinusitis

1 reference

12 December 2020

Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.

1 reference

12 December 2020

Clinical relevance of intracellular and extracellular concentrations of macrolides

1 reference

12 December 2020

Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections.

1 reference

12 December 2020

The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance

1 reference

12 December 2020

A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin

1 reference

12 December 2020

Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group.

1 reference

12 December 2020

Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections

1 reference

12 December 2020

Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis

1 reference

12 December 2020

Streamlining antimicrobial therapy for lower respiratory tract infections

1 reference

12 December 2020

Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis

1 reference

12 December 2020

Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

1 reference

12 December 2020

Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections

1 reference

12 December 2020

Novelties in the field of anti-infectives in 1997.

1 reference

12 December 2020

Flurithromycin ethylsuccinate in the treatment of lower respiratory tract bacterial infections

1 reference

12 December 2020

Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification

1 reference

12 December 2020

Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha

1 reference

12 December 2020

Relevance of the Alexander Project: pharmacodynamic considerations

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

Roxithromycin 150 mg b.i.d. versus amoxycillin 500 mg/clavulanic acid 125 mg t.i.d. for the treatment of lower respiratory tract infections in general practice

1 reference

12 December 2020

Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin.

1 reference

12 December 2020

Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group

1 reference

12 December 2020

Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis

1 reference

12 December 2020

Erythromycin: drug interactions

1 reference

12 December 2020

A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school

1 reference

12 December 2020

Empiric antibiotic selection criteria for respiratory infections in pediatric practice

1 reference

12 December 2020

Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.

1 reference

12 December 2020

Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.

1 reference

12 December 2020

In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria

1 reference

12 December 2020

Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Antimicrobial treatment of community acquired pneumonia in adults: A conference report

1 reference

12 December 2020

Comparison of clarithromycin suspension and amoxycillin syrup for the treatment of children with pharyngitis and/or tonsillitis

1 reference

12 December 2020

Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.

1 reference

12 December 2020

A cross-Canada surveillance of antimicrobial resistance in respiratory tract pathogens

1 reference

12 December 2020

Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group

1 reference

12 December 2020

Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis

1 reference

12 December 2020

Comparison of roxithromycin with co-amoxiclav in patients with sinusitis.

1 reference

12 December 2020

Tissue distribution of dirithromycin: comparison with erythromycin

1 reference

12 December 2020

Economic analysis of antibiotic regimens used in the treatment pharyngitis: a prospective comparison of azithromycin versus roxithromycin.

1 reference

12 December 2020

The New Macrolide Antibiotics: Azithromycin, Clarithromycin, Dirithromycin, and Roxithromycin

1 reference

12 December 2020

Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children.

1 reference

12 December 2020

New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy

1 reference

12 December 2020

Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis

1 reference

12 December 2020

Intravenous azithromycin-induced ototoxicity

1 reference

12 December 2020

Acute otitis media in the 1990s: the impact of antibiotic resistance

1 reference

12 December 2020

In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.

1 reference

12 December 2020

The pharmacokinetics of azithromycin in human serum and tissues

1 reference

12 December 2020

Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children

1 reference

12 December 2020

Pharmacoeconomic impact of factors affecting compliance with antibiotic regimens in the treatment of acute otitis media

1 reference

12 December 2020

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

1 reference

12 December 2020

Susceptibilities of Legionella spp. to newer antimicrobials in vitro

1 reference

12 December 2020

Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia

1 reference

12 December 2020

Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens

1 reference

12 December 2020

Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin

1 reference

12 December 2020

Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia

1 reference

12 December 2020

A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis

1 reference

12 December 2020

Drug associated hepatic reactions in New Zealand: 21 years experience

1 reference

12 December 2020

Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis

1 reference

12 December 2020

Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens--findings of the Alexander Project 1992-1996.

1 reference

12 December 2020

Intracellular distribution and activity of antibiotics

1 reference

12 December 2020

Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections

1 reference

12 December 2020

Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.

1 reference

12 December 2020

Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents

1 reference

12 December 2020

In-vitro activity of dirithromycin in comparison with other new and established macrolides

1 reference

12 December 2020

Practical considerations and guidelines for the management of community-acquired pneumonia

1 reference

12 December 2020

An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections.

1 reference

12 December 2020

Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study

1 reference

12 December 2020

Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae

1 reference

12 December 2020

Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis

1 reference

12 December 2020

Macrolides versus azalides: a drug interaction update

1 reference

12 December 2020

Managing otitis media: a time for change

1 reference

12 December 2020

Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children

1 reference

12 December 2020

A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children.

1 reference

12 December 2020

Novel mechanism of macrolide resistance in Streptococcus pneumoniae

1 reference

12 December 2020

In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.

1 reference

12 December 2020

A randomized comparative study on the safety and efficacy of clarithromycin and erythromycin in treating community-acquired pneumonia

1 reference

12 December 2020

Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay

1 reference

12 December 2020

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

1 reference

12 December 2020

Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis

1 reference

12 December 2020

Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants

1 reference

12 December 2020

Uptake of Flurithromycin by Human Polymorphonuclear Phagocytes: Partial Characterization of the Entry Mechanism

1 reference

12 December 2020

Tissue-directed pharmacokinetics

1 reference

12 December 2020

Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network

1 reference

12 December 2020

Efficacy of roxithromycin in the treatment of mycoplasma pneumonia

1 reference

12 December 2020

A multicenter, open label trial of azithromycin for the treatment of children with acute otitis media

1 reference

12 December 2020

Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study

1 reference

12 December 2020

Penetration of macrolides into human polymorphonuclear leucocytes

1 reference

12 December 2020

Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic

1 reference

12 December 2020

Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides

1 reference

12 December 2020

Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients

1 reference

12 December 2020

Drug interactions with azithromycin and the macrolides: an overview

1 reference

12 December 2020

Penetration of clarithromycin into middle ear fluid of children with acute otitis media

1 reference

12 December 2020

Azithromycin: the first of the tissue-selective azalides

1 reference

12 December 2020

Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem

1 reference

12 December 2020

Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study

1 reference

12 December 2020

Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

1 reference

12 December 2020

Roxithromycin: a pharmacokinetic review of a macrolide

1 reference

12 December 2020

Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications

1 reference

12 December 2020

Comparative pharmacokinetics of macrolides

1 reference

12 December 2020

In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.

1 reference

12 December 2020

Comparison of dirithromycin and penicillin for treatment of streptococcal pharyngitis

1 reference

12 December 2020

Susceptibilities of 228 penicillin- and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents

1 reference

12 December 2020

Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae

1 reference

12 December 2020

In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.

1 reference

12 December 2020

Functional consequences of binding macrolides to ribosomes.

1 reference

12 December 2020

1 reference

12 December 2020

Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group

1 reference

12 December 2020

The influence of cisapride and clarithromycin on QT intervals in healthy volunteers.

1 reference

12 December 2020

Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of newer macrolides

1 reference

12 December 2020

Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens

1 reference

12 December 2020

A comparative study of dirithromycin and erythromycin in bacterial pneumonia

1 reference

12 December 2020

Comparison of spiramycin with erythromycin for lower respiratory tract infections.

1 reference

12 December 2020

An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media.

1 reference

12 December 2020

Choosing an antibiotic on the basis of pharmacodynamics.

1 reference

12 December 2020

Prevention of drug access to bacterial targets: permeability barriers and active efflux

1 reference

12 December 2020

Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group

1 reference

12 December 2020

Chemistry and mode of action of macrolides

1 reference

12 December 2020

New macrolides: expanded horizons for an old class of antibiotics

1 reference

12 December 2020

Adverse effects of macrolide antibacterials

1 reference

12 December 2020

Predicting the efficacy of antimicrobial agents in respiratory infections--is tissue concentration a valid measure?

1 reference

12 December 2020

In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.

1 reference

12 December 2020

Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles

1 reference

12 December 2020

Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group

1 reference

12 December 2020

Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia

1 reference

12 December 2020

Clinical microbiology of azithromycin

1 reference

12 December 2020

The site concentrations of antimicrobial agents in the lung

1 reference

12 December 2020

An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis.

1 reference

12 December 2020

Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial

1 reference

12 December 2020

10.2165/00003495-200161040-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1014531107

0 references

1 reference